Cite
AAV9- TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome.
MLA
Suzuki-Hatano, Silveli, et al. “AAV9- TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome.” Molecular Therapy. Methods & Clinical Development, vol. 13, Jan. 2019, pp. 167–79. EBSCOhost, https://doi.org/10.1016/j.omtm.2019.01.007.
APA
Suzuki-Hatano, S., Saha, M., Soustek, M. S., Kang, P. B., Byrne, B. J., Cade, W. T., & Pacak, C. A. (2019). AAV9- TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome. Molecular Therapy. Methods & Clinical Development, 13, 167–179. https://doi.org/10.1016/j.omtm.2019.01.007
Chicago
Suzuki-Hatano, Silveli, Madhurima Saha, Meghan S Soustek, Peter B Kang, Barry J Byrne, W Todd Cade, and Christina A Pacak. 2019. “AAV9- TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome.” Molecular Therapy. Methods & Clinical Development 13 (January): 167–79. doi:10.1016/j.omtm.2019.01.007.